Funding for this research was provided by:
Health Research Council of New Zealand (17-726)
Received: 15 August 2017
Accepted: 5 February 2018
First Online: 5 March 2018
: DS (MBChB, MPH, PhD) is Professor and Director of the Cancer and Chronic Conditions (C3) Research Group at University of Otago, Wellington.MM (MBChB, MPH) is a public health physician with expertise in Māori health research, primary care and health economics.JaS (PhD) is a biostatistician.VS (BN, MPH, PhD) has nursing and public health expertise.JeS (Dip Nurs, MPH) has primary care and Māori healthcare expertise.JK (MBChB, MD) is an endocrinologist and current member of the Ministry of Health National Diabetes Leadership group.AD (MBChB) is a Professor of Primary Care.WL (MSc) is a health economist with expertise in clinical trials and mHealth interventions.CD (DIBM) has primary care and Māori healthcare expertise.RG (MBChB, PhD) is a physician and mHealth researcher
: Ethics approval was granted by the New Zealand Health and Disability Ethics Central Committee (17/CEN/49). We will obtain informed consent from all participants in the study.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.